» Articles » PMID: 16740478

Apc Tumor Suppressor Gene is the "zonation-keeper" of Mouse Liver

Overview
Journal Dev Cell
Publisher Cell Press
Date 2006 Jun 3
PMID 16740478
Citations 218
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanisms by which liver genes are differentially expressed along a portocentral axis, allowing for metabolic zonation, are poorly understood. We provide here compelling evidence that the Wnt/beta-catenin pathway plays a key role in liver zonation. First, we show the complementary localization of activated beta-catenin in the perivenous area and the negative regulator Apc in periportal hepatocytes. We then analyzed the immediate consequences of either a liver-inducible Apc disruption or a blockade of Wnt signaling after infection with an adenovirus encoding Dkk1, and we show that Wnt/beta-catenin signaling inversely controls the perivenous and periportal genetic programs. Finally, we show that genes involved in the periportal urea cycle and the perivenous glutamine synthesis systems are critical targets of beta-catenin signaling, and that perturbations to ammonia metabolism are likely responsible for the death of mice with liver-targeted Apc loss. From our results, we propose that Apc is the liver "zonation-keeper" gene.

Citing Articles

A platform for multimodal pooled genetic screens reveals regulators of liver function.

Saunders R, Allen W, Pan X, Sandhu J, Lu J, Lau T bioRxiv. 2024; .

PMID: 39605605 PMC: 11601512. DOI: 10.1101/2024.11.18.624217.


Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.

Kluiver T, Lu Y, Schubert S, Kraaier L, Ringnalda F, Lijnzaad P Nat Commun. 2024; 15(1):8576.

PMID: 39567475 PMC: 11579375. DOI: 10.1038/s41467-024-52757-w.


Cell competition in primary and metastatic colorectal cancer.

van Luyk M, Krotenberg Garcia A, Lamprou M, Suijkerbuijk S Oncogenesis. 2024; 13(1):28.

PMID: 39060237 PMC: 11282291. DOI: 10.1038/s41389-024-00530-5.


Emerging role of oncogenic ß-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma.

Dantzer C, Vache J, Brunel A, Mahouche I, Raymond A, Dupuy J Elife. 2024; 13.

PMID: 39008536 PMC: 11249736. DOI: 10.7554/eLife.95191.


The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma.

Hu N, Li H, Tao C, Xiao T, Rong W Int J Mol Sci. 2024; 25(11).

PMID: 38891772 PMC: 11171976. DOI: 10.3390/ijms25115584.